Shawn Singh - 12 May 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Jerrold D. Dotson, Attorney-in-Fact
Issuer symbol: VTGN
Transactions as of: 12 May 2022
Net transactions value: +$100,000
Form type: 4
Filing time: 16 May 2022, 13:39:31 UTC
Previous filing: 03 Mar 2022
Next filing: 15 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VTGN	Common Stock	Options Exercise	$100,000	+100,000	+204%	$1.00^*	148,998	12 May 2022	Direct
holding	VTGN	Common Stock						26,234	12 May 2022	By The 1997 Singh Family Trust U/R/D 05/29/97

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTGN	Stock Option (Right to Buy)	Options Exercise	$0	-100,000	-59%	$0.000000	70,000	12 May 2022	Common Stock	100,000	$1.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Stock option vested 25% on the grant date of September 5, 2019, with the remainder vesting monthly over the 36 months thereafter.